Molecular structure and transcriptional regulation by nuclear factor-κB of the mouse kinin B1 receptor gene

Biological Chemistry

Volumn 386, Issue 6, 2005, Pages 515-522

  Merino, Vanessa F ^a   Silva Jr , José A ^a   Araújo, Ronaldo C ^b   Avellar, Maria C W ^a   Bascands, Jean L ^c   Schanstra, Joost P ^c   Paiva, Antonio C M ^a   Bader, Michael ^d   Pesquero, João B ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^c CHU RANGUEIL   (France)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Enhancer; Lipopolysaccharide (LPS); Mouse kinin B1 receptor gene; Multiple transcription start sites; Nuclear factor B (NF B); Promoter; VSMC

Indexed keywords

G PROTEIN COUPLED RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KININ B1 RECEPTOR; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; DNA FLANKING REGION; EXON; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR GENE; RECEPTOR UPREGULATION; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BASE SEQUENCE; DNA; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; RECEPTOR, BRADYKININ B1; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 26844446863     PISSN: 14316730     EISSN: 14316730     Source Type: Journal    
DOI: 10.1515/BC.2005.061     Document Type: Article

References (42)

1. 1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1β in vivo in the mouse. J. Immunol. 156, 269-274.
2. Alenina, N., Baranova, T., Smirnow, E., Bader, M., Lippoldt, A., Patkin, E., and Walther, T. (2002). Cell type-specific expression of the Mas proto-oncogene in testis. J. Histochem. Cytochem. 50, 691-696.
3. 1). Genomics 33, 374-381
4. Bergmann, M., Hart, L., Lindsay, M., Barnes, P.J., and Newton, R. (1998). IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-1β and tumor necrosis factor α-induced κB-dependent transcription. Requirement for an additional activation pathway. J. Biol. Chem. 273, 6607-6610.
5. Bhoola, K.D., Figueroa, C.D., and Worthy, K. (1992). Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44, 1-80.
6. Borges, M.O., Abreu, M.L., Porto, C.S., and Avellar, M.C. (2001). Characterization of muscarinic acetylcholine receptor in rat Sertoli cells. Endocrinology 142, 4701-4710.
7. 1 receptors: key Gprotein-coupled receptors and their role in inflammatory and painful processes. Br. J. Pharmacol. 143, 803-818.
8. Cayla, C., Merino, V.F., Cabrini, D.A., Silva, J.A. Jr., Pesquero, J.B., and Bader, M. (2002). Structure of the mammalian kinin receptor gene locus. Int. Immunopharmacol. 2, 1721-1727.
9. 1 receptor for therapeutic angiogenesis. Circulation 105, 360-366.
10. 2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction. J. Biol. Chem. 273, 2617-2623.
11. Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
12. Hall, J.M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56, 131-190.
13. Hess, J.F., Borkowski, J.A., Young, G.S., Strader, C.D., and Ransom, R.W. (1992). Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem. Biophys. Res. Commun. 184, 260-268.
14. Karin, M., Cao, Y., Greten, F.R., and Li, Z.W. (2002). NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310.
15. Krappmann, D., Wulczyn, F.G., and Scheidereit, C. (1996). Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J. 15, 6716-6726.
16. Lawrence, R., Chang, L.J., Siebenlist, U., Bressler, P., and Sonenshein, G.E. (1994). Vascular smooth muscle cells express a constitutive NF-κ B-like activity. J. Biol. Chem. 269, 28913-28918.
17. MacNeil, T., Bierilo, K.K., Menke, J.G., and Hess, J.F. (1995). Cloning and pharmacological characterization of a rabbit bradykinin B1-receptor. Biochim. Biophys. Acta 1264, 223-228.
18. Marceau, F., Larrivee, J.-F., Saint-Jacques, E., and Bachvarov, D.R. (1997). The kinin B1 receptor: an inducible G protein coupled receptor. Can. J. Physiol. Pharmacol. 75, 725-730.
19. 1 receptors for kinins. Pharmacol. Rev. 50, 357-386.
20. 2 bradykinin receptor. Proc. Natl. Acad. Sci. USA 88, 7724-7728.
21. McLean, P.G., Perretti, M., and Ahluwalia, A. (2000). Kinin B1 receptors and the cardiovascular system: regulation of expression and function. Cardiovasc. Res. 48, 194-210.
22. 1 bradykinin receptor. J. Biol. Chem. 269, 21583-21586.
23. 1 receptor. Biochim. Biophys. Acta 1442, 177-185.
24. 1 receptor gene in inflammation. J. Biol. Chem. 273, 2784-2791.
25. 2 receptor gene. Evidence for alternative splicing. J. Biol. Chem. 269, 26920-26925.
26. 1-receptor gene. Biochem. Biophys. Res. Commun. 220, 219-225.
27. 1 receptors. Proc. Natl. Acad. Sci. USA 97, 8140-8145.
28. 1 in human lung fibroblasts. Mol. Pharmacol. 56, 325-333.
29. Proudfoot, N. (1991). Poly(A) signals. Cell 64, 671-674.
30. Regoli, D. and Barabé, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1-46.
31. 2 receptor on nociception in rats and mice. Pain 71, 89-97.
32. Saccani, S., Pantano, S., and Natoli, G. (2002). p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3, 69-75.
33. 1 receptors in rat aortic smooth muscle cells. Biochem. Pharmacol. 61, 291-298.
34. 1-receptor in cultured human lung fibroblasts. J. Clin. Invest. 101, 2080-2091.
35. Schulze-Osthoff, K., Ferrari, D., Riehemann, K., and Wesselborg, S. (1997) Regulation of NF-κB activation by MAP-kinase cascades. Immunobiology 198, 35-49.
36. Smale, S.T. (1994). In: Transcription: Mechanisms and Regulation, R.C. Conaway and J.W. Conaway, eds. (New York, USA: Raven Press), pp. 63-81.
37. Takadera, T., Leung, S., Gernone, A., Koga, Y., Takihara, Y., Miyamoto, N.G., and Mak, T.W. (1989). Structure of the two promoters of the human lck gene: differential accumulation of two classes of lck transcripts in T cells. Mol. Cell. Biol. 9, 2173-2180.
38. Ten, R.M., Paya, C.V., Israel, N., Le Bail, O., Mattei, M.G., Virelizier, J.L., Kourilsky, P., and Israel, A. (1992). The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J. 11, 195-203.
39. Ueberla, K., Lu, Y., Chung, E., and Haseltine, W.A. (1993). The NF-κB p65 promoter. J. Acquir. Immune Defic. Syndr. 6, 227-230.
40. 9-BK in mouse pleurisy. Br. J. Pharmacol. 123, 281-291.
41. 1 receptor gene expression. Identification of a minimum cell-type specific enhancer. J. Biol. Chem. 273, 10763-10770.
42. 1 receptor gene expression. Biochem. J. 330, 361-366.